Biopharmaceuticals
Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company committed to the development of innovative products that have the potential to restore the health of people with cardiovascular disease. The company has three programs in the mid to late stages of clinical development that are based on its autologous CD34+ cell therapy platform to treat coronary microvascular dysfunction, critical limb ischemia and no-option refractory disabling angina.
Douglas Losordo
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.